Objective To explore the impact of medication-related osteonecrosis of the jaw (MRONJ) on quality of life and to explore the attitudes and perceptions of patients towards the multidisciplinary approach to the prevention of the condition. Design Interpretivist methodology using qualitative semistructured interviews. Setting Primary care general medical practices and secondary care dental services in England. Participants 23 patients; 6 with MRONJ, 13 prescribed bisphosphonates, 4 with osteoporosis not currently prescribed any medication. Results Patients felt that MRONJ had a significant negative impact on their quality of life and had poor knowledge of the preventive strategies recommended in the literature. Patients demonstrated positive a...
Background Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare, yet significant, adver...
Introduction: Medication related osteonecrosis of the jaw (MRONJ) is exposed bone in the maxillofaci...
BACKGROUND: MRONJ (medication related osteonecrosis of the jaws) is a well-known side effect of cer...
Objective To explore the impact of medication-related osteonecrosis of the jaw (MRONJ) on quality of...
Objective To explore the impact of medication-related osteonecrosis of the jaw (MRONJ) on quality of...
Background: Medication related osteonecrosis of the jaw (MRONJ), is a rare adverse effect of anti-re...
ObjectiveTo explore general dental practitioners’ (GDPs’) perceptions of, and attitudes towards, the...
Background: Bisphosphonate related osteonecrosis of the jaw (BRONJ), is a rare, yet significant, adv...
Osteoporosis is the most common indication for antiresorptive drugs (ARDs). Medication-related osteo...
Background Bisphosphonate medication can cause osteonecrosis of the jaw, which is an uncommon but se...
Background Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare, yet significant, adver...
Introduction: Medication related osteonecrosis of the jaw (MRONJ) is exposed bone in the maxillofaci...
BACKGROUND: MRONJ (medication related osteonecrosis of the jaws) is a well-known side effect of cer...
Objective To explore the impact of medication-related osteonecrosis of the jaw (MRONJ) on quality of...
Objective To explore the impact of medication-related osteonecrosis of the jaw (MRONJ) on quality of...
Background: Medication related osteonecrosis of the jaw (MRONJ), is a rare adverse effect of anti-re...
ObjectiveTo explore general dental practitioners’ (GDPs’) perceptions of, and attitudes towards, the...
Background: Bisphosphonate related osteonecrosis of the jaw (BRONJ), is a rare, yet significant, adv...
Osteoporosis is the most common indication for antiresorptive drugs (ARDs). Medication-related osteo...
Background Bisphosphonate medication can cause osteonecrosis of the jaw, which is an uncommon but se...
Background Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare, yet significant, adver...
Introduction: Medication related osteonecrosis of the jaw (MRONJ) is exposed bone in the maxillofaci...
BACKGROUND: MRONJ (medication related osteonecrosis of the jaws) is a well-known side effect of cer...